Jürgen Werani

Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model the authors describe the current status of OPEX and the future challenges that have to be dealt with. The ample theoretical background is complemented hand-in-hand by case studies contributed by authors from leading pharmaceutical companies.​

In order to face a new market reality, Operational Excellence initiatives will build the cornerstones of future operations strategies in the pharmaceutical sector. The biggest challenge is and will be the engagement of people. The authors of this book point out that it will be the ability to make each employee think in terms of continuous improvement and change that will enable companies to overcome the organizations internal inertia and separate the winners from the losers. Leading managers, consultants and researchers from both sides of the Atlantic contributed to this second book about a topic that has already started to change the way thousands of employees understand and do their jobs. As an addition to the first book Operational Excellence in the Pharmaceutical Industry which focused on the essence of OPEX, this book focuses on the managerial and organizational aspects of comprehensive Operational Excellence programs.